A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial

Journal:

Nature Medicine

Published:

2026-02-16

DOI:

10.1038/s41591-025-04154-z

Affiliations:

8

Authors:

18

Go to article

Institutions	Authors	Share
Helus - UK, United Kingdom (UK)	8.000000	0.44
Imperial College London (ICL), United Kingdom (UK)	4.000000	0.22
Hammersmith Medicines Research Ltd., United Kingdom (UK)	2.000000	0.11
MBJ Counselling, United Kingdom (UK)	1.000000	0.06
Johns Hopkins University (JHU), United States of America (USA)	1.000000	0.06
UCL, United Kingdom (UK)	1.000000	0.06
University of California, San Francisco (UCSF), United States of America (USA)	1.000000	0.06

Interested in Clinical Sciences?